サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1678749

Gタンパク質共役型受容体の市場規模、シェア、動向分析レポート：製品別、用途別、アッセイ別、地域別、セグメント予測、2025年～2030年

G-protein Coupled Receptors Market Size, Share & Trends Analysis Report By Product (Cell Lines, Detection Kits), By Application (Cancer Research, CNS Research), By Assay, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
Gタンパク質共役型受容体の市場規模、シェア、動向分析レポート：製品別、用途別、アッセイ別、地域別、セグメント予測、2025年～2030年
出版日: 2025年02月18日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Gタンパク質共役型受容体市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のGタンパク質共役型受容体市場規模は、2025～2030年にかけてCAGR 6.10％を記録し、2030年までに55億5,000万米ドルに達すると予測されています。

潜在的なGタンパク質共役受容体（GPCR）標的治療を開発するために、製薬企業による高速で正確な高性能スクリーニング（HTS）技術の採用が増加していることが、市場の成長を増大させると予想されています。HTSは、Gタンパク質共役受容体の細胞ベースのアッセイに利用され、複数の医薬品開発プログラムを支援します。

Gタンパク質共役型受容体（GPCR）の構造的・機能的特徴は、ホルモン、刺激物質、神経伝達物質に対する生理的反応を媒介することを可能にするため、様々な疾患の潜在的な治療標的となります。GPCRの構造生物学における最近の進歩により、これらの受容体の活性化と活性化の分子メカニズムに関する洞察が得られています。複数の製薬企業が、いくつかの疾患に対するGタンパク質共役受容体を標的とした治療の開発に取り組んでいます。

2018年12月、ベーリンガーインゲルハイムはDomain Therapeuticsと共同で、がん、中枢神経系（CNS）、免疫疾患の治療のためのGPCR標的を発見しました。さらに2019年5月、Evotec OAI AGはEuroscreen S.A.と提携し、GPCRターゲティングの能力を向上させました。Evotec OAIは創薬手順のためにEuroscreenのGPCR試薬とAequoScreenTM技術にアクセスします。このようなイニシアチブは、製薬産業における薬剤スクリーニングの専門知識だけでなく、製品の採用を強化します。

北米は、米国における創薬と開発手順の需要増に対応するためのがん研究への投資が活発であるため、予測期間を通じて市場の最前線に立つと考えられます。同地域では、治療の開発や受託研究が増加しており、Gタンパク質共役型受容体市場の成長を後押ししています。

Gタンパク質共役型受容体市場のレポートハイライト

  • 製品別では、アッセイ用の細胞株が豊富に揃っていることから、細胞株セグメントが2022年に最大の収益シェアを獲得し、市場を独占しました。
  • 環状アデノシン一リン酸はGPCRシグナル伝達における重要な細胞内セカンドメッセンジャーです。
  • がん研究セグメントが市場を独占し、2024年には31.5%の最大収益シェアを占めました。Gタンパク質共役型受容体の活性は、様々な疾患の治療に応用されています。
  • 北米のGタンパク質共役型受容体産業は、がん研究への戦略的投資、GPCR標的薬の承認、創薬開発活動への重点化により、2024年に36.9%の最大売上高シェアで世界を支配しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 Gタンパク質共役受容体市場の変数と動向

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 産業分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 Gタンパク質共役受容体：製品別、推定・動向分析

  • 製品セグメントダッシュボード
  • Gタンパク質共役受容体市場：製品変動分析
  • Gタンパク質結合受容体市場規模と動向分析、製品別、2018～2030年
  • 細胞株
    • 細胞株市場推定・予測、2018～2030年
  • 検出キット
    • 検出キット市場推定・予測、2018～2030年
  • 細胞培養試薬
    • 細胞培養試薬市場推定・予測、2018～2030年
  • リガンド
    • リガンド市場推定・予測、2018～2030年

第5章 Gタンパク質共役受容体：アッセイ別、推定・動向分析

  • アッセイセグメントダッシュボード
  • Gタンパク質共役受容体市場：アッセイ変動分析
  • Gタンパク質結合受容体市場規模と動向分析、アッセイ別、2018～2030年
  • cAMP機能アッセイ
    • cAMP機能アッセイ市場推定・予測、2018～2030年
  • カルシウム機能アッセイ
    • カルシウム機能アッセイ市場推定・予測、2018～2030年
  • B-アレスチン機能アッセイ
    • B-アレスチン機能アッセイ市場推定・予測、2018～2030年
  • 放射性リガンド結合とGTPYS機能アッセイ
    • 放射性リガンド結合とGTPYS機能アッセイ市場推定・予測、2018～2030年
  • 国際化アッセイ
    • 国際化アッセイ市場推定・予測、2018～2030年
  • 輸送アッセイ
    • 輸送アッセイ市場推定・予測、2018～2030年
  • その他のアッセイ
    • その他のアッセイ市場推定・予測、2018～2030年

第6章 Gタンパク質共役受容体：用途別、推定・動向分析

  • 用途セグメントダッシュボード
  • Gタンパク質共役受容体市場：用途変動分析
  • Gタンパク質結合受容体市場規模と動向分析、用途別、2018～2030年
  • がん研究
    • がん研究市場推定・予測、2018～2030年
  • 中枢神経系研究
    • 中枢神経系研究市場推定・予測、2018～2030年
  • 代謝研究
    • 代謝研究市場推定・予測、2018～2030年
  • 心血管研究
    • 心血管研究市場推定・予測、2018～2030年
  • 炎症研究
    • 炎症研究市場推定・予測、2018～2030年
  • 呼吸器研究
    • 呼吸器研究市場推定・予測、2018～2030年
  • その他
    • その他推定・予測、2018～2030年

第7章 Gタンパク質共役受容体市場：地域別、推定・動向分析

  • 地域別市場ダッシュボード
  • 地域別市場シェア分析、2024年と2030年
  • 地域別Gタンパク質共役受容体市場：主要ポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 参入企業
  • 企業市況分析、2024年
  • 参加者概要
    • Thermo Fisher Scientific Inc.
    • Eurofins Scientific
    • QIAGEN
    • WuXi AppTec
    • Promega Corporation
    • Abcam plc
    • Merck KGaA
    • PerkinElmer Inc.
    • Enzo Biochem Inc.
    • BD
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 4 North America G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America G-protein coupled receptors market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 8 U.S. G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 9 Canada G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 11 Canada G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 12 Mexico G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 14 Mexico G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 17 Europe G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe G-protein coupled receptors market, by region, 2018 - 2030 (USD Million)
  • Table 19 Germany G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 21 Germany G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 22 UK G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 23 UK G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 24 UK G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 25 France G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 26 France G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 27 France G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 28 Italy G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 29 Italy G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 30 Italy G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 31 Spain G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 32 Spain G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 33 Spain G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 34 Sweden G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 36 Sweden G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 37 Norway G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 39 Norway G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 41 Denmark G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 42 Denmark G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific G-protein coupled receptors market, by region, 2018 - 2030 (USD Million)
  • Table 47 China G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 48 China G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 49 China G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 50 Japan G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 51 Japan G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 52 Japan G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 53 India G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 54 India G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 55 India G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 56 Australia G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 58 Australia G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 59 Thailand G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 61 Thailand G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 63 South Korea G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 64 South Korea G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 66 Latin America G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 67 Latin America G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 68 Latin America G-protein coupled receptors market, by region, 2018 - 2030 (USD Million)
  • Table 69 Brazil G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 70 Brazil G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 71 Brazil G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 72 Argentina G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 74 Argentina G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa G-protein coupled receptors market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 81 South Africa G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 85 UAE G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 87 UAE G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)
  • Table 88 Kuwait G-protein coupled receptors market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait G-protein coupled receptors market, by assay, 2018 - 2030 (USD Million)
  • Table 90 Kuwait G-protein coupled receptors market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 G-protein coupled receptors: market outlook
  • Fig. 9 G-protein coupled receptors competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Industry value chain analysis
  • Fig. 13 G-protein coupled receptors market driver impact
  • Fig. 14 G-protein coupled receptors market restraint impact
  • Fig. 15 G-protein coupled receptors market strategic initiatives analysis
  • Fig. 16 G-protein coupled receptors market: Product movement analysis
  • Fig. 17 G-protein coupled receptors market: Product outlook and key takeaways
  • Fig. 18 Cell lines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Detection kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cell culture reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Ligands market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 G-protein coupled receptors market: Assay movement analysis
  • Fig. 23 G-protein coupled receptors market: Assay outlook and key takeaways
  • Fig. 24 cAMP functional assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Calcium functional assays market estimates and forecasts, 2018 - 2030
  • Fig. 26 B-Arrestin functional assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Radioligand binding and GTPYS functional assays market estimates and forecasts, 2018 - 2030
  • Fig. 28 Internalization assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Trafficking assays market estimates and forecasts, 2018 - 2030
  • Fig. 30 Other assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 G-protein coupled receptors market: Application movement analysis
  • Fig. 32 G-protein coupled receptors market: Application outlook and key takeaways
  • Fig. 33 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 CNS research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Metabolic research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Cardiovascular research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Inflammation research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Respiratory research market estimates and forecasts, 2018 - 2030
  • Fig. 39 Other applications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Global G-protein coupled receptors market: Regional movement analysis
  • Fig. 41 Global G-protein coupled receptors market: Regional outlook and key takeaways
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-3-68038-224-2

G-Protein Coupled Receptors Market Growth & Trends:

The global G-protein coupled receptors market size is expected to reach USD 5.55 billion by 2030 registering a CAGR of 6.10% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising adoption of faster and accurate High-Throughput Screening (HTS) technology by pharmaceutical firms to develop potential G-protein coupled receptor(GPCR)-targeted therapeutics is expected to augment the market growth. HTS is used on the G-protein coupled receptor cell-based assays to assist several drug development programs.

Structural and functional features of G-protein coupled receptors (GPCRs) allow it to mediate physiological responses to hormones, stimulants, and neurotransmitters, thus making them as potential therapeutic targets for various diseases. Recent advancements in the structural biology of GPCRs have provided insights into the molecular mechanisms of these receptors' activation and activity. Several pharmaceutical companies are undertaking efforts to develop G-protein coupled receptors-targeted therapeutics for several disorders.

In December 2018, Boehringer Ingelheim collaborated with Domain Therapeutics to discover GPCR targets for the treatment of cancer, Central Nervous System (CNS), and immunological disorders. Moreover, in May 2019, Evotec OAI AG partnered with Euroscreen S.A. to improve its capabilities for GPCR targeting. Evotec OAI will access GPCR reagents and AequoScreenTM technology of Euroscreen for its drug discovery procedures. Such initiatives enhance the product adoption as well as drug screening expertise in the pharmaceutical industry.

North America is likely to be at the forefront of the market throughout the forecast period due to heavy investments in cancer research to address the rising demand for drug discovery and development procedures in U.S. Whereas, Asia Pacific is expected to register the fastest CAGR over the forecast years. The region witnesses a rising number of therapeutics development and contract research, thus boosting G-protein coupled receptors market growth.

G-Protein Coupled Receptors Market Report Highlights:

  • Based on products, the cell lines segment dominated the market with the largest revenue share in 2022, owing to the availability of an extensive range of cell lines for the assays.
  • The cAMP functional assays segment dominated the market with the largest revenue share of 32.5% in 2024 because cyclic Adenosine Monophosphate is an important intracellular second messenger in GPCR signal transduction.
  • The cancer research segment dominated the market, with the largest revenue share of 31.5% in 2024. Many applications are associated with G-protein-coupled receptor activity for treating several disorders.
  • North America G-Protein coupled receptors industry dominated globally with the largest revenue share of 36.9% in 2024 due to strategic investments in cancer research, approval of GPCR-targeted drugs, and increased focus on drug discovery & development activities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Assay
    • 1.1.3. Application
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. G-protein Coupled Receptors Market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. G-protein Coupled Receptors: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. G-protein Coupled Receptors Market: Product Movement Analysis
  • 4.3. G-protein Coupled Receptors Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Cell lines
    • 4.4.1. Cell lines market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Detection kits
    • 4.5.1. Detection kits market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Cell Culture Reagents
    • 4.6.1. Cell culture reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Ligands
    • 4.7.1. Ligands market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. G-protein Coupled Receptors: Assay Estimates & Trend Analysis

  • 5.1. Assay Segment Dashboard
  • 5.2. G-protein Coupled Receptors Market: Assay Movement Analysis
  • 5.3. G-protein Coupled Receptors Market Size & Trend Analysis, by Assay, 2018 to 2030 (USD Million)
  • 5.4. cAMP Functional Assays
    • 5.4.1. cAMP functional assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Calcium Functional Assays
    • 5.5.1. Calcium functional assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. B-Arrestin Functional Assays
    • 5.6.1. B-Arrestin functional assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Radioligand Binding and GTPYS Functional Assays
    • 5.7.1. Radioligand binding and GTPYS functional assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Internationalization Assays
    • 5.8.1. Internationalization assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Trafficking Assays
    • 5.9.1. Trafficking assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. Other Assays
    • 5.10.1. Other assays market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. G-protein Coupled Receptors: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. G-protein Coupled Receptors Market: Application Movement Analysis
  • 6.3. G-protein Coupled Receptors Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Cancer Research
    • 6.4.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. CNS Research
    • 6.5.1. CNS research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Metabolic Research
    • 6.6.1. Metabolic research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Cardiovascular Research
    • 6.7.1. Cardiovascular research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Inflammation Research
    • 6.8.1. Inflammation research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9. Respiratory Research
    • 6.9.1. Respiratory research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.10. Other Applications
    • 6.10.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. G-protein Coupled Receptors Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. G-protein Coupled Receptors Market by Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.3. South Africa
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Participant Overview
    • 8.3.1. Thermo Fisher Scientific Inc.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Eurofins Scientific
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. QIAGEN
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. WuXi AppTec
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Promega Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Abcam plc
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Merck KGaA
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. PerkinElmer Inc.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Enzo Biochem Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. BD
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives